ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer
María Pilar Carrera-González(Universidad de Jaén), Carla Ripamonti(Fondazione IRCCS Istituto Nazionale dei Tumori), María L. Amador(Sidney Kimmel Comprehensive Cancer Center), George Pentheroudakis(University of Ioannina), Maria Pisu(University of Alabama at Birmingham), Eva C. Winkler(Heidelberg University), Dario Trapani(Harvard University), Sakari Karjalainen(Tampere University), Raymond J. Chan(Queensland University of Technology), Margaret I. Fitch(University of Toronto), Gianmauro Numico(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Nandita Khera(Mayo Clinic in Florida), Nathan I. Cherny, Linda Sharp(Newcastle University), Daniele Santini(Università Campus Bio-Medico), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Mark Lawler(Queen's University Belfast), F. Meunier, Giuseppe Curigliano(European Institute of Oncology)
Cited by 54
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k